New Clinical Alert Issued
New Clinical Alert Issued. NLM Technical Bulletin. 2003 Sep–Oct;(334):e1.
October 20, 2003 [posted]
The National Cancer Institute (NCI) has issued a new Clinical Alert:
A Canadian-led international clinical trial found that post-menopausal survivors of early-stage breast cancer who took the drug letrozole after completing an initial five years of tamoxifen therapy had a significantly reduced risk of cancer recurrence compared to women taking a placebo.
Links to Clinical Alerts can also be found from these NLM Web sites:
- MedlinePlus features Clinical Alerts as NIH Press Releases on the appropriate Health Topics page(s).
- As before, PubMed and the NLM Gateway have a link to the Clinical Alerts on their side bars. In addition, a featured link will now be available from their Home Page for 10 days after a new alert is issued.